Crossmark

Rationally designed PMAP-23 derivatives with enhanced bactericidal and anticancer activity based on the molecular mechanism of peptide–membrane interactions

Crossref DOI link: https://doi.org/10.1007/s00726-023-03290-5

Published Online: 2023-06-13

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Hyunhee

Shin, Sung-Heui

Yang, Sungtae
Funding

Funding for this research was provided by:

Research fund from Chosun University (Chosun University (2021), Chosun University (2021), Chosun University (2021))
License Information

Text and Data Mining valid from 2023-06-13

Version of Record valid from 2023-06-13
More Information

Article History

Received: 30 March 2023

Accepted: 5 June 2023

First Online: 13 June 2023

Declarations

:

: The authors declare no competing financial interests.

: This article does not contain any studies with human or animal participants.

Document is current

Any future updates will be listed below